http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8500663-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0dfa756d8d95385994f1521f13bdf5b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54306
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
filingDate 1983-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c740240c07ebe6e6c45742f2e6986f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a30e89efe0a19aa33e60e2b23a024b28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86bd7ce83b187eac5ecd08a975d38af6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc33b5d610d2b55ea42f177aa69953f5
publicationDate 1985-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-8500663-A1
titleOfInvention Immunometric assay using polyclonal and monoclonal antibodies and a kit for use therein
abstract "Two-site" or "sandwich" immunometric assay techniques for determination of the presence and/or concentration of antigenic substances in fluids using a combination of monoclonal and polyclonal antibodies. One antibody selected from a group consisting of monoclonalx and polyclonal(1-x) antibodies is presented in a soluble labeled form; a second antibody selected from a group consisting of monoclonal(1-x) and polyclonalx is presented bound to a solid carrier; and x is 0 or 1. The present invention further encompasses a kit comprising in association: (a) a soluble first antibody to an antigenic substance present in a fluid to be assayed, the first antibody being labeled and being selected from a group consisting of monoclonalx and polyclonal(1-x) antibodies; and (b) a second antibody to the antigenic substance, the second antibody being bound to a solid carrier and being selected from a group consisting of monoclonal(1-x) and polyclonalx antibodies; wherein x is 0 or 1.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0315447-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5798083-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0214520-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0249983-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6083709-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8808535-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0201079-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5779976-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0263401-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5316914-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0452503-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5770459-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6078782-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0201079-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5434051-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0452503-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6881589-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8840774-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6325973-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0171871-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8601411-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0289335-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-590216-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0214520-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0289335-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0249983-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4921790-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0315447-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H01503177-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5935779-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5654159-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8211279-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5962218-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4722889-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5705402-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5746974-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4935339-A
priorityDate 1983-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4361647-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0062892-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0042755-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0048357-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4016043-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8201773-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7243
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397727

Total number of triples: 61.